BlackRock Investment Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock Investment Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Hold	1,848	–	–	﹤0.01%	3602
2016 Q3	$10K	Hold	1,848	–	–	﹤0.01%	3607
2016 Q2	$13K	Hold	1,848	–	–	﹤0.01%	3541
2016 Q1	$12K	Hold	1,848	–	–	﹤0.01%	3560
2015 Q4	$19K	Buy	1,848 +60	+3%	+$696	﹤0.01%	3454
2015 Q3	$21K	Hold	1,788	–	–	﹤0.01%	3433
2015 Q2	$16K	Sell	1,788 -83	-4%	-$627	﹤0.01%	3538
2015 Q1	$12K	Hold	1,871	–	–	﹤0.01%	3601
2014 Q4	$10K	Hold	1,871	–	–	﹤0.01%	3701
2014 Q3	$11K	Buy	1,871 +162	+9%	+$988	﹤0.01%	3649
2014 Q2	$12K	Buy	+1,709	New	+$11.4K	﹤0.01%	3584

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

BlackRock Investment Management's JNP Position: Q4 2016 in Review

BlackRock Investment Management held its Juniper Pharmaceuticals, Inc. Common Stock (JNP) position steady in Q4 2016 at 1,848 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

BlackRock Investment Management first reported a position in JNP in Q2 2014 and has held it in 11 quarters since. The position peaked at $21K in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

BlackRock Investment Management held 1,848 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $10K as of Q4 2016.
BlackRock Investment Management left its Juniper Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2016.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3602 holding.
BlackRock Investment Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.